Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
20 μg recombinant hepatitis B vaccine (Hansenula) vs recombinant hepatitis B vaccine (yeast) in adults
CTR20132136Phase 3Active
- Sponsor
- Hualan Biological Vaccine
- Start
- Sep 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant hepatitis b vaccine (hansenula polymorpha) in hepatitis B (HBV), sponsored by Hualan Biological Vaccine. Started Sep 2014; status: active.
02
Drugs
recombinant hepatitis b vaccine (hansenula polymorpha)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on CTR20132136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132136.